Department of Food and Human Nutritional Sciences, Faculty of Agriculture and Food Sciences, University of Manitoba, 110 RCFTR 196 Innovation Dr, Winnipeg, MB, R3T 2N2, Canada.
Chronic Disease Innovation Center, Seven Oaks General Hospital, Winnipeg, MB, Canada.
Trials. 2023 Oct 24;24(1):689. doi: 10.1186/s13063-023-07708-z.
A significant proportion of Canadian adults is impacted by chronic noncommunicable diseases. These conditions may be improved by peer-led health promotion interventions that target modifiable risk factors; however, to date, there is mixed evidence on the effectiveness of these interventions. Unlike other health promotion programs, Hans Kai is grounded in a holistic model of health that simultaneously addresses multiple determinants of health at different levels of human ecology. In Hans Kai, a set of informational sessions that are delivered in a group setting by healthcare professionals are followed by regular peer-led group meetings in a self-governed support group setting that is designed to promote implementation of newly learned health competences. The Hans Kai trial described here aims to evaluate the efficacy of the Hans Kai program in promoting the health and wellbeing of its participants and investigate the experiences of the Hans Kai participants and facilitators.
This research will involve a mixed methods trial combining an experimental component with a qualitative component. The experimental component will involve a 6-month 2-group parallel superiority randomized controlled trial (RCT) in which 105 participants will be randomly assigned to two conditions, an intervention group (n = 70) that will participate in the Hans Kai program and a control group (n = 35) that will have access to standard care using a computer-generated random sequence; blinding will not occur. The RCT will test the impact of the program on several health outcomes and will be followed by a 12-18-month observational follow-up study that will provide data on the long-term durability of the 6-month RCT health outcomes. The qualitative component will investigate the experiences of program participants (n = 30) and facilitators (n = 15) to identify the main strengths and limitations of Hans Kai, uncover potential implementation issues, and elucidate the mechanisms through which the program works. The population of interest will include adults aged 18 + with or without chronic health conditions who self-report an interest in taking control of their own health and improving their lifestyle. In the RCT, all outcomes of interest will be measured using a multi-method approach, involving self-report questionnaires and objective indicators, and within-subject mean changes in outcomes over time between the two groups will be compared to address the RCT aims. Similarly, in the qualitative component, a multi-method approach, involving in-depth individual interviews, photovoice, and online surveys, will be used to reach a deeper and more nuanced understanding of the program strengths, how the program works, and for which people it is more effective. Adaptable components of the program will also be investigated and modified according to the feedback provided by the RCT participants. In the mixed methods integration of evidence, the qualitative findings will be used to explain the quantitative RCT results.
The RCT findings will help support the further development and use of Hans Kai as well as other peer-led health promotion interventions.
United Stated Clinical Trial Registry ClinicalTrials.gov (registration# NCT03949725; Protocol version 2, June 22nd, 2022).
相当一部分加拿大成年人受到慢性非传染性疾病的影响。这些疾病可以通过针对可改变的危险因素的同伴主导的健康促进干预来改善;然而,迄今为止,这些干预措施的效果存在混合证据。与其他健康促进计划不同,汉斯·凯伊(Hans Kai)基于健康的整体模型,同时在人类生态的不同层次上解决多种健康决定因素。在汉斯·凯伊(Hans Kai)中,一组由医疗保健专业人员在小组环境中提供的信息会议,随后是定期的同伴主导的小组会议,在自我管理的支持小组环境中进行,旨在促进新学到的健康能力的实施。这里描述的汉斯·凯伊(Hans Kai)试验旨在评估汉斯·凯伊(Hans Kai)计划在促进参与者健康和福祉方面的功效,并调查汉斯·凯伊(Hans Kai)参与者和促进者的经验。
这项研究将涉及一项混合方法试验,将实验部分与定性部分相结合。实验部分将包括一项为期 6 个月的 2 组平行优势随机对照试验(RCT),其中 105 名参与者将被随机分配到两种情况,干预组(n=70)将参加汉斯·凯伊(Hans Kai)计划,对照组(n=35)将获得使用计算机生成的随机序列的标准护理;不会出现盲法。该 RCT 将测试该计划对多种健康结果的影响,并随后进行 12-18 个月的观察性随访研究,该研究将提供有关 6 个月 RCT 健康结果长期耐久性的数据。定性部分将调查计划参与者(n=30)和促进者(n=15)的经验,以确定汉斯·凯伊(Hans Kai)的主要优势和局限性,发现潜在的实施问题,并阐明该计划的工作机制。感兴趣的人群将包括年龄在 18 岁及以上的成年人,无论是否患有慢性健康状况,他们都表示有兴趣控制自己的健康并改善自己的生活方式。在 RCT 中,所有感兴趣的结果都将使用多方法方法进行测量,包括自我报告问卷和客观指标,并且将比较两组之间随时间变化的结果的个体内平均变化,以解决 RCT 目标。同样,在定性部分,将使用多方法方法,包括深入的个人访谈、摄影声音和在线调查,以更深入和更细致地了解该计划的优势、该计划的工作原理以及对哪些人更有效。还将根据 RCT 参与者提供的反馈调查该计划的适应性组成部分并进行修改。在混合方法证据综合中,定性发现将用于解释定量 RCT 结果。
RCT 结果将有助于支持汉斯·凯伊(Hans Kai)和其他同伴主导的健康促进干预措施的进一步发展和使用。
美国临床试验注册处 ClinicalTrials.gov(注册号 NCT03949725;协议版本 2,2022 年 6 月 22 日)。